Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Rivian Stock on December 8, 2025: Downgrade, Recall and R2 Hopes – What RIVN Investors Need to Know

Rivian Stock on December 8, 2025: Downgrade, Recall and R2 Hopes – What RIVN Investors Need to Know

As of Monday afternoon, Rivian shares were trading around $17.30, down roughly 3–5% on the day, with intraday trading between about $17.05 and $17.70. That pullback comes after a strong rally from the April 2024 low of about $8.26 and a 12‑month gain in the high 30% range, even though the stock is still down roughly 90% from its 2021 peak near $172.FinancialContent+1
8 December 2025
Structure Therapeutics (GPCR) Stock Soars on Obesity Pill Data: Latest News, Analyst Forecasts and 2026 Outlook (December 8, 2025)

Structure Therapeutics (GPCR) Stock Soars on Obesity Pill Data: Latest News, Analyst Forecasts and 2026 Outlook (December 8, 2025)

On Monday, December 8, 2025, the company released positive topline data from its ACCESS program for aleniglipron, a once‑daily oral GLP‑1 receptor agonist for obesity. The market response was immediate: GPCR closed at $69.46, up about 101% on the day, after trading between $24.83 and an intraday high of $94.90.
Canada’s F‑35 Crossroads: Quebec Maintenance Hub, Leaked Scorecard and a Last‑Minute Gripen Push

Canada’s F‑35 Crossroads: Quebec Maintenance Hub, Leaked Scorecard and a Last‑Minute Gripen Push

Canada’s long‑running fighter jet saga has erupted into a full‑blown political and industrial showdown as of December 8, 2025. A leaked Department of National Defence scoring chart strongly favoring the U.S.‑made F‑35, an aggressive push to turn Mirabel, Quebec into a major F‑35 maintenance hub, and a fresh wave of opinion pieces and lobbying on both sides of the F‑35–vs–Gripen debate are all converging just as Prime Minister Mark Carney edges toward a decision on the country’s next‑generation fighter fleet. SSBCrack News+3National Security Journal+3WLS 890 AM+3
8 December 2025
UK Mortgage Rates Hit Pre‑Mini‑Budget Lows as China’s $1 Trillion Trade Surplus Shifts the Global Outlook

UK Mortgage Rates Hit Pre‑Mini‑Budget Lows as China’s $1 Trillion Trade Surplus Shifts the Global Outlook

London / Beijing – 8 December 2025 – Homeowners in the UK woke up today to the most competitive mortgage market since before the turmoil of the 2022 mini‑budget, just as China confirmed its trade surplus has smashed through the $1 trillion mark for the first time. Together, these stories tell you something important: the global backdrop for interest rates, mortgages and inflation is changing – again.
8 December 2025
Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals’ stock is back in the spotlight on 8 December 2025 after the company reported encouraging mid‑stage trial results for its AI‑discovered drug REC‑4881 in a rare, cancer‑linked condition called familial adenomatous polyposis. The news gives investors something they’ve been waiting on for years: early clinical proof that Recursion’s AI‑driven platform might actually work in real patients. GlobeNewswire+1
HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

HanesBrands Inc. has effectively disappeared as a stand‑alone stock. On December 1, 2025, Gildan Activewear Inc. closed its long‑awaited acquisition of HanesBrands, turning the iconic underwear maker into a wholly owned subsidiary and triggering the suspension and planned delisting of HBI shares from the New York Stock Exchange. GlobeNewswire+1
Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery, Inc. is suddenly less about box office and more about boardrooms. On Monday, December 8, 2025, the stock jumped sharply after Paramount Skydance lobbed a $30-per-share hostile all‑cash offer at the company, directly challenging Netflix’s already-announced acquisition of Warner Bros.’ studios and streaming assets.TheWrap+1
8 December 2025
1 528 529 530 531 532 608

Google Preferred Source

Stock Market Today